Toronto Stock Exchange Symbol: MS
EDMONTON, April 29 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at a session entitled "Leveraging on energy wealth: the development of a world class technology sector" as part of the Alberta Economic Forum in Geneva in Switzerland.
WHEN: Monday May 4th at 10:05am (Local time) WHERE: Grand Hotel Kempinski, Geneva, Switzerland About Alberta Economic Forum ----------------------------
The Alberta Economic Forum will profile direct and financial investment opportunities while also addressing the environmental, economical and technological issues critical to the long term success of investment in Alberta. With an anticipated 300 attendees, participants of the forum will include investment bankers, portfolio managers, independent wealth managers, private investors, financial analysts, and portfolio managers from both Europe and Canada, in addition to senior managers of the infrastructure sector and government. For more information visit http://www.albertaeconomicforum.com/
About BioMS Medical Corp. -------------------------
BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for Secondary Progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide in exchange for an $87 million upfront payment, mile
|SOURCE BioMS Medical Corp.|
Copyright©2009 PR Newswire.
All rights reserved